INGN vs. IVC, ZJYL, SMTI, LAKE, CLGN, APT, NTRB, MLSS, COCH, and RBOT
Should you be buying Inogen stock or one of its competitors? The main competitors of Inogen include Invacare (IVC), Jin Medical International (ZJYL), Sanara MedTech (SMTI), Lakeland Industries (LAKE), CollPlant Biotechnologies (CLGN), Alpha Pro Tech (APT), Nutriband (NTRB), Milestone Scientific (MLSS), Envoy Medical (COCH), and Vicarious Surgical (RBOT). These companies are all part of the "surgical appliances & supplies" industry.
Invacare (NYSE:IVC) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, community ranking, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.
Invacare has higher revenue and earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Invacare, indicating that it is currently the more affordable of the two stocks.
In the previous week, Inogen had 2 more articles in the media than Invacare. MarketBeat recorded 2 mentions for Inogen and 0 mentions for Invacare. Invacare's average media sentiment score of 1.43 beat Inogen's score of 0.62 indicating that Inogen is being referred to more favorably in the news media.
Inogen has a consensus target price of $7.00, indicating a potential downside of 15.66%.
59.9% of Invacare shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 6.9% of Invacare shares are held by company insiders. Comparatively, 1.0% of Inogen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Invacare has a net margin of -9.99% compared to Invacare's net margin of -30.07%. Inogen's return on equity of -37.76% beat Invacare's return on equity.
Inogen received 121 more outperform votes than Invacare when rated by MarketBeat users. Likewise, 70.44% of users gave Inogen an outperform vote while only 53.54% of users gave Invacare an outperform vote.
Invacare has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500. Comparatively, Inogen has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500.
Summary
Invacare beats Inogen on 8 of the 15 factors compared between the two stocks.
Get Inogen News Delivered to You Automatically
Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding INGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
